The study of the tumor myeloid compartment showed, that while the number of microglia increased with the anti-CD40, the levels of macrophages and monocytes were significantly higher with the virus and the combination compared to IgG control- or anti-CD40-treated groups (Figure 4A). This evidence concerns the gene CD40 and neoplasm.